Profile data is unavailable for this security.
About the company
Joinn Laboratories China Co Ltd is a China-based company primarily engaged in the pharmacology and toxicology research of new drugs. Non-clinical research services include drug safety evaluation, pharmacokinetic research as well as pharmacological and pharmacodynamic research. Clinical trials and related services include clinical contract research organization services, phase I clinical research collaboration unit (CRU), and bioanalysis services. Experimental model business mainly includes rodents and non-human primates. The Company conducts its businesses both in the domestic market and overseas markets.
- Revenue in HKD (TTM)2.57bn
- Net income in HKD428.58m
- Incorporated1998
- Employees2.51k
- LocationJoinn Laboratories China Co LtdA5 Rongjing East StreetEconomic-Technological Development AreaBEIJING 100176ChinaCHN
- Phone+86 1 067869582
- Fax+86 1 067869966
- Websitehttps://www.joinnlabs.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Alphamab Oncology | 236.18m | -227.35m | 2.09bn | 435.00 | -- | 1.16 | -- | 8.87 | -0.2364 | -0.2364 | 0.246 | 1.87 | 0.1028 | 0.7705 | 19.34 | 542,948.80 | -9.90 | -18.72 | -11.69 | -21.94 | 74.75 | -- | -96.26 | -415.55 | 5.55 | -- | 0.1333 | -- | 31.12 | -- | 35.35 | -- | -13.12 | -- |
CARsgen Therapeutics Holdings Ltd | 0.00 | -807.30m | 2.39bn | 516.00 | -- | 1.23 | -- | -- | -1.45 | -1.45 | 0.00 | 3.38 | 0.00 | -- | -- | 0.00 | -29.79 | -- | -32.14 | -- | -- | -- | -- | -- | 9.54 | -- | 0.0452 | -- | -- | -- | 16.19 | -- | -- | -- |
Biocytogen Pharmaceuticals Beijng Co Ltd | 773.96m | -413.42m | 2.77bn | 1.07k | -- | 3.27 | -- | 3.58 | -1.04 | -1.04 | 1.94 | 2.12 | 0.2732 | 16.21 | 5.74 | 726,040.90 | -14.59 | -- | -18.88 | -- | 70.59 | -- | -53.42 | -- | 1.24 | -21.30 | 0.4077 | -- | 34.28 | -- | 36.38 | -- | -- | -- |
Qyuns Therapeutics Co Ltd | 0.00 | -548.15m | 4.73bn | 331.00 | -- | 14.86 | -- | -- | -2.47 | -2.47 | 0.00 | 1.43 | -- | -- | -- | 0.00 | -- | -- | -- | -- | -- | -- | -- | -- | 1.64 | -69.52 | 0.5349 | -- | -- | -- | -70.28 | -- | -- | -- |
ImmuneOnco Biopharmaceuticls Shanghi Inc | -100.00bn | -100.00bn | 4.83bn | 145.00 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -28.25 | -- | 5.82 | -- | -- | -- |
Lepu Biopharma Co Ltd | 243.28m | -23.85m | 4.99bn | 429.00 | -- | 5.00 | 64.15 | 20.53 | -0.0144 | -0.0144 | 0.1466 | 0.5835 | 0.0917 | 1.06 | 1.62 | 567,096.00 | -1.23 | -- | -1.91 | -- | 87.45 | -- | -13.45 | -- | 0.7201 | 0.1388 | 0.4549 | -- | 1,347.16 | -- | 96.79 | -- | -- | -- |
Ascentage Pharma Group International | 239.65m | -999.29m | 8.50bn | 583.00 | -- | 120.13 | -- | 35.45 | -3.53 | -3.53 | 0.8489 | 0.2248 | 0.0833 | 2.38 | 2.22 | 411,060.30 | -34.73 | -44.93 | -52.82 | -57.04 | 86.24 | 87.68 | -417.02 | -976.10 | 1.42 | -15.03 | 0.9622 | -- | 5.85 | 100.76 | -4.84 | -- | 2.82 | -- |
Keymed Biosciences Inc | 382.27m | -387.95m | 8.57bn | 897.00 | -- | 2.66 | -- | 22.43 | -1.49 | -1.49 | 1.45 | 11.52 | 0.0906 | 0.7314 | 26.14 | 426,167.00 | -9.16 | -- | -10.05 | -- | 89.59 | -- | -101.04 | -- | 9.18 | -- | 0.123 | -- | 253.87 | -- | -16.63 | -- | -- | -- |
InnoCare Pharma Ltd | 797.31m | -681.50m | 9.30bn | 1.09k | -- | 1.03 | -- | 11.67 | -0.4041 | -0.4041 | 0.4725 | 4.38 | 0.073 | 1.39 | 3.39 | 732,144.50 | -6.38 | -13.41 | -8.08 | -15.36 | 82.61 | 85.99 | -87.42 | -172.16 | 4.13 | -- | 0.1582 | -- | 18.09 | 240.36 | 28.80 | -- | 66.20 | -- |
Joinn Laboratories China Co Ltd | 2.57bn | 428.58m | 10.32bn | 2.51k | 11.92 | 0.5713 | 18.09 | 4.02 | 0.5714 | 0.5714 | 3.42 | 11.92 | 0.2331 | 1.11 | 7.19 | 1,022,149.00 | 3.84 | 8.92 | 4.59 | 11.01 | 41.21 | 46.67 | 16.48 | 32.00 | 4.11 | -- | 0.0083 | 24.51 | 4.78 | 42.20 | -63.04 | 30.36 | 8.21 | -- |
RemeGen Co Ltd | 1.16bn | -1.63bn | 12.27bn | 3.62k | -- | 2.01 | -- | 10.56 | -3.03 | -3.03 | 2.16 | 6.90 | 0.1864 | 0.4005 | 4.31 | 321,372.60 | -26.17 | -18.66 | -31.75 | -23.75 | 76.48 | 81.94 | -140.43 | -102.88 | 1.31 | -64.32 | 0.2682 | -- | 40.16 | 148.65 | -51.30 | -- | 59.07 | -- |
Genscript Biotech Corp | 6.55bn | -745.33m | 26.55bn | 6.94k | -- | 2.44 | -- | 4.05 | -0.3538 | -0.3538 | 3.11 | 5.12 | 0.283 | 7.59 | 5.45 | 944,745.40 | -11.97 | -18.34 | -18.27 | -26.15 | 48.78 | 54.68 | -42.30 | -64.91 | 4.65 | -- | 0.1694 | -- | 34.17 | 29.44 | 57.91 | -- | 17.14 | -- |
Data as of Jul 30 2024. Currency figures normalised to Joinn Laboratories China Co Ltd's reporting currency: Hong Kong Dollar HKD
26.00%Per cent of shares held by top holders
Holder | Shares | % Held |
---|---|---|
Brown Brothers Harriman & Co. (Investment Management)as of 05 Mar 2024 | 5.73m | 4.82% |
UBS Asset Management (Hong Kong) Ltd.as of 14 Jun 2024 | 5.45m | 4.58% |
The Vanguard Group, Inc.as of 04 Jul 2024 | 3.90m | 3.28% |
FIL Investment Management (Singapore) Ltd.as of 06 Mar 2024 | 3.67m | 3.08% |
FIL Investment Management (Hong Kong) Ltd.as of 06 Mar 2024 | 3.36m | 2.82% |
abrdn Investment Management Ltd.as of 15 Mar 2024 | 3.31m | 2.78% |
Abrdn Asia Ltd.as of 15 Mar 2024 | 1.78m | 1.49% |
GF Fund Management Co., Ltd.as of 31 Dec 2023 | 1.56m | 1.31% |
BlackRock Advisors (UK) Ltd.as of 24 Apr 2023 | 1.51m | 1.27% |
JPMorgan Investment Management, Inc.as of 15 Nov 2023 | 674.83k | 0.57% |
More ▼
Data from 31 Dec 2023 - 31 May 2024Source: FactSet Research Systems Inc.